I used to think of Solazyme as the Apple of Algae, so maybe it's now like Apple in the past when it traded at the equivalent of today's prices. I'd be fine if it morphed into the Google of Algae too.
Algae has so many uses that Solazyme isn't even involved in yet. They could make lectins from algae that capture viruses and exosomes from cancers and provide them to supply the hemopurifiers that will one day be ubiquitous in treating infections, cancers and purifying transfusable blood.
If only an Elon Musk was running the show, the company might inspire more confidence.
Hopefully they can weather the current difficulties and find a way to profitability.
It got down to .34 in 2002, so anything is possible. With heavy debt, a devaluing currency, a tough business climate in Brazil and global weakness in growth, we have a perfect storm.
Try 15+ years. Aethlon Medical was founded in May 1998!
I tried that with Worldcom and it didn't work out so well. We may have to hold bake sales to keep it going. Of course we'll bake everything with algavia flour.
Tesla buyers don't worry about gas prices and the same with most electric car buyers. It's about sparing the air, less maintenance and saving the planet than saving money.
How can PWE hold even these levels if oil continues to drop and stayed dropped? A very challenging environment indeed. As tempted as I am to average down, I think I'll wait. I think they're foolish for not at least temporarily suspending the dividend until oil prices stabilize higher and they've substantially reduce debt further.
It's already been proven safe and effective at rapidly decreasing viral load and exosomal load from the blood, thus giving the body a fighting chance. Unfortunately, they need the blessing of the FDA for full approval in the U.S. Like I've said many times, they should focus outside the U.S. for acceptance and let U.S. medical tourists come to them. FDA (Foot Dragging Administration) is not their friend.
In the midst of daily Ebola news, Aethlon should be getting mentioned in the media on a daily basis. Aethlon is very poor at PR or managing it's trademark. The Aethlon hemopurifier should be a household word by now and people should be demanding the right for access to it as a treatment option.
With almost no income other than DARPA they'll have to raise a ton o' cash to get through the molasses of full FDA approval. So, as a result the stock price could easily drift back to 20 cents or less. In the meantime many will die unnecessarily when they could be saved by treatments from a hemopurifier.
The U.S. gubmint should prop up these nascent companies if need be. In the name of national insecurity, if nothing else. I thought the U.S. was supposed to be trying to end its over-dependence on foreign oil.
While they're at it, they can pay off peewee's debt too. ;-)
Anyone who bought this stock has been fracked. Looks like it's heading below a buck if the trend doesn't reverse. A month more of tax loss selling potential.
Every article on the hemopurifier tells you what it does, as does the name of the device. It's not called the viroliminator. It's only cleaning the blood, it can't do anything about viruses that have entered other cells of the body. It eliminates exosomes as well. It's a huge deal. It can give those with nasty viral infections and many with cancer a fighting chance as well, since many believe exosomes are part of allowing metastases (cancer spreading). It is also a diagnostic tool.
They've always called it adjunct treatment, which it can be, but I think they've always couched it that way to try and diminish the threat that drug companies may feel from such a device. The main side effect from treatment is cleaner blood, virus-free, exosome free. The fact that it hasn't been massively deployed in the Ebola stricken zones is insane. It's just wrong.
To my mind it borders on criminal that this treatment is denied to millions who could benefit from it for so many things. It's disruptive, and the encumbents don't like disruptive.
It's not a scam.
It's just that it's still probably a few years away from total approval. It's only approved for emergency use right now. It's a stupid law in many respects. It's really been proven safe and does what it says it does. I think it's also a miracle that Michael Mawanda survived. The HP only gets rid of stuff in the blood, not what has entered the organs. But apparently the HP gave him a fighting chance and his body rebounded. The HP should really be used as a first line of treatment, not as a last resort. That's the insanity of the FDA's stupid rule.
I don't understand why Aethlon doesn't offer services directly to the affected countries in exchange for collecting the data on before and after results. Perhaps they could be remunerated some funds to cover some of the expenses.
The patient was near death with multiple organs under attack from Ebola and he's alive. The government should be begging Aethlon to make hemopurifiers as fast as they can. It was already proven safe and effective in India studies. One day the HP will be standard issue part of every dialysis machine in the world.
All blood transfusions should be run through it as well, just as a precaution to prevent any potential viral transfer.
Looks like pricing will be close to $40K and manufactured in China at first. More details:
If Roberts was concerned about long term shareholders he'd eliminate the DRIP program which is dilutive.
Suspending the dividend temporarily until ship is righted wouldn't be a bad idea either. In the meantime it looks like languishing is what it's doing.
What's telling is that they've known about this for 4 years and done nothing about it. I think it's indicative of poor management. It takes a phone call and/or an email to demand a cease and desist.
Give a lawyer 10,000 shares to take care of returning the domain name to its rightful owner.
Their sole product's name has been hijacked.
I guess I'm the only one who doesn't think it's trivial.
Why trademark something if you're not going to protect it?
It reflects badly on the company.
I guess most of you are all caught up in the run-up frenzy.